Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

EEG-based graph network analysis in relation to regional tau in asymptomatic Alzheimer’s disease
Spruyt, Laure , Mlinarič, Tjaša , Dusart, Nathalie, Reinartz, Mariska , Meade, Gabriela , Dupont, Patrick , Van Hulle, Marc M , Meade, Gabriela , Laere, Koen Van , Vandenberghe, Rik

Brain Communications | April 15, 2025 | Volume: 7 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcaf138 | PMID 40255689 Get It

Abstract Tau aggregation in early affected regions in the asymptomatic stage of Alzheimer’s disease marks a transitional phase between stable asymptomatic amyloid positivity and the clinically manifest stage. How this early region tau aggregation covertly affects brain function during this asymptomatic stage remains unclear. In this study, 83 participants underwent a 128 electrodes resting-state EEG, a dynamic 100 min tau PET scan (18F-MK6240), an amyloid PET scan, a structural T1 MRI scan and neuropsychological assessment. Tau PET data quality control led to a final sample of 66 subjects. Based on the clinical and cognitive status, amyloid and tau PET biomarkers, the group was composed of 37 cognitively unimpaired amyloid negative subjects, 14 cognitively unimpaired amyloid positive subjects and 15 patients with prodromal Alzheimer’s disease. We calculated the average undirected weighted Phase Lag Index in the alpha frequency band with eyes closed and used this as weights for the graph and analysed the global clustering coefficient and characteristic path length in sensor space. As a primary objective, we assessed how these global graph measures correlated with tau PET values, in an a priori defined early metaVOI, comprised of the entorhinal and perirhinal cortex, hippocampus, parahippocampus and fusiform cortex. As secondary analyses, we investigated which specific brain regions were mainly implicated, what the contribution was of amyloid, the effect of electrode density and the relation to cognitive performance. In the overall group and within the cognitively unimpaired amyloid positive subgroup, tau aggregation was associated with a decrease in global clustering coefficient and an increase in characteristic path length. These changes reflect the initial disintegration of the small-world brain network during the transitional phase, even before clinical symptoms are apparent. The correlations are most prominent in the perirhinal cortex, indicating that global deterioration of the network is already present early in the Alzheimer’s disease pathology. We obtained similar results with only taking 64 electrodes into account. To conclude, we found that in the asymptomatic stage of Alzheimer’s disease, tau PET load in medial temporal cortex is associated with global electrophysiological measures of network disintegration. The study demonstrates the potential value of high-density EEG in the era of biologically defined Alzheimer’s disease for characterizing brain function in the asymptomatic stage.
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
Puttkammer, Jenna R. , Barreto, Jason N. , Jensen, Chelsee , Nedved, Adrienne, Wilson-Miller, Justine L., Cole, Kristin C., Holmes, Lucy , Kosobud, A., Kapoor, Prashant , Gertz, Morie A. , Dingli, David , Kumar, Shaji , Hayman, Suzanne R. , Kourelis, Taxiarchis , Warsame, Rahma , Binder, Moritz , Sandahl, Tyler B. , Mara, Kristin C. , Jensen, Chelsee J , Nedved, Adrienne N , Holmes, Lucy M, Kosobud, Allison R, Gonsalves, Wilson , Kumar, Shaji K , Kourelis, Taxiarchis V, Warsame, Rahma , Binder, Moritz , Cook, Joselle M , Lin, Yi , Sandahl, Tyler B , Gertz, Morie A , Dingli, David , Mara, Kristin C , Holmes, Lucy M., Kosobud, Allison R., Gonsalves, Wilson I. , Cook, Joselle , Lin, Yi

JCO Oncology Practice | April 15, 2025 | Volume: 22 | Issue: 1 | Pages: 83-90

10.1200/op-24-00930 | PMID 40233295 Get It

PURPOSE Cytokine release syndrome (CRS) of any grade occurs in 56%-80% of bispecific antibodies (BsAbs) used in multiple myeloma (MM). Risk mitigation strategies are required to expedite escalation of care if toxicities develop. The rarity of grade 3 or 4 CRS compels protocolized outpatient management of BsAbs as outpatient practice may avoid hospital admissions and costly resource utilization without compromising safety. MATERIALS AND METHODS Patients with MM who received BsAb step-up dosing (SUD) from August 23, 2023, to March 29, 2024, were enrolled. Baseline demographics, patient outcomes, and CRS management were reviewed to assess the safety of outpatient practice. Resource utilization was also analyzed. RESULTS In this study, 34 patients received outpatient SUD of BsAbs (teclistamab n = 17, talequetamab n = 17) with 16 remaining outpatient throughout the entire SUD period. CRS occurred in seven patients who did not require hospitalization, demonstrating the safety of outpatient management of BsAb toxicity, regardless of low-grade CRS. CRS was observed in 24 patients (maximum grade 2) and immune effector cell–associated neurotoxicity syndrome in four patients (maximum grade 3). All patients with CRS received steroids, including 12 patients at home when instructed. Tocilizumab was given to 13 patients, accounting for 18 doses. If all doses of BsAbs and tocilizumab were given outpatient, the medication margin would be $115,004 in US dollars (USD). CONCLUSION An outpatient-based practice for BsAb administration demonstrated safety and cost savings. The description of our practice and results of this study provide valuable insights into the safety, feasibility, and resource stewardship of outpatient management of BsAbs. Future research should attempt to predict and stratify CRS risk to deliver a tailored supportive strategy and continued increase of outpatient management.
Research Derived From Medicare’s Coverage With Evidence Development Program
Janda, Guneet, Moneer, Osman , Mooghali, Maryam , Wallach, Joshua D., Dhruva, Sanket S. , Wallach, Joshua D. , Janda, Guneet S, Wallach, Joshua D , Ramachandran, Reshma , Ross, Joseph S.

JAMA Network Open | April 15, 2025 | Volume: 8 | Issue: 4 | Pages: e255077

10.1001/jamanetworkopen.2025.5077 | PMID 40232723 Get It

This cross-sectional study assesses published research articles about medical items and services approved by the Coverage With Evidence Development program to characterize their scientific impact.
A Diagnostic Dilemma: Disseminated Histoplasmosis Presenting as a Small-Bowel Obstruction
Stoll, Nicolas Tapia, Saleh, Hasan , Jackson, Brittany , Baptista, Aleksandra Murawska , Oring, Justin , Durvasula, Ravi , Nakhleh, Raouf E. , Kinnucan, Jami , Kashani, Daniel , Tapia Stoll, Nicolas , Murawska Baptista, Aleksandra, Al Hashash, Jana G, Oring, Justin , Stoll, Nicolas Tapia, Hashash, Jana G.

American Journal of Case Reports | April 15, 2025 | Volume: 26 | Issue: No issue available | Pages: No page available

10.12659/ajcr.946515 | PMID 40383940 Get It

A commentary on “Unusual presentation of desiderosmia in major depressive disorder: A case series of four patients from Eastern India”
Borré, Carla I., Borré, Carla Isabel, Go, Ronald S.

Indian Journal of Psychiatry | April 15, 2025 | Volume: 67 | Issue: 4 | Pages: 441-442

10.4103/indianjpsychiatry.indianjpsychiatry_902_24 | PMID 40371256 Get It

To the Editor: In response to “A Perspective on Promotion in Place and Competency-Based, Time-Variable Graduate Medical Education”—Reply
Rose, Steven H., Long, Timothy R.

Journal of Graduate Medical Education | April 15, 2025 | Volume: 17 | Issue: 2 | Pages: 244-245

10.4300/jgme-d-25-00173.1 | PMID 40417108 Get It

A Structured Approach to Mitigating Cognitive Bias in Educational Assessment
Meunier, Matthew R. , Theofiles, Meghan , González, César A. , Theofiles, Meghan G , Gonzalez, Cesar , Meunier, Matthew R

Journal of Graduate Medical Education | April 15, 2025 | Volume: 17 | Issue: 2 | Pages: 136-139

10.4300/jgme-d-24-00734.1 | PMID 40417102 Get It

Ectopic Liver Mimicking Neoplastic Lesions: Report of Five Patients and Literature Review
Jain, Ekta , Amoa, Falone, Memon, Raima , Korremla, Niraja Shainoju , Ajmal, Imran Thariq , Patel, Chirag , Winokur, Thomas S. , Ghandour, Fatme , Diffalha, Sameer Al , Patel, Chirag R, Al Diffalha, Sameer , Amoa, Falone C. , Ajmal, Imran

International Journal of Surgical Pathology | April 15, 2025 | Volume: 33 | Issue: 7 | Pages: 1672-1678

10.1177/10668969251331581 | PMID 40232280 Get It

Ectopic liver is a rare congenital anomaly characterized by the presence of liver tissue outside the normal liver without any direct connection to it. These lesions are usually detected incidentally during clinical evaluation for other issues. However, they sometimes mimic neoplastic lesions both clinically and radiologically, which poses diagnostic challenges. Here, we present 5 patients with ectopic liver, 4 of which mimicked neoplastic lesions. The first was a 54-year-old woman diagnosed with multiple liver lesions and an enlarged gastro-hepatic lymph node, suspected to be a primary hepatic neoplasm with metastasis. Upon resection, it was found to be a hepatocellular adenoma in the liver and intraabdominal ectopic liver tissue with a small hepatocellular adenoma. Patient 2 was a 36-year-old woman presenting with palpitations and shortness of breath. An echocardiogram revealed a right atrial mass, which was identified as ectopic liver upon microscopic examination. The third patient was a 57-year-old woman with intermittent abdominal pain who underwent cholecystectomy. Microscopy revealed ectopic liver tissue on the gallbladder's serosal surface, along with chronic cholecystitis. The fourth was a 36-year-old woman with a gallbladder polyp, which on microscopy revealed ectopic liver tissue with no other abnormalities in the gallbladder. The fifth patient was a 57-year-old woman presenting with shortness of breath, weakness, and right atrial mass, which was confirmed as ectopic liver. These patients illustrate varied presentations of ectopic liver, sometimes mimicking neoplasia. Hepatocellular adenomas arising in ectopic liver and ectopic liver in intracardiac locations are extremely rare and can be a diagnostic pitfall, as they can clinically, radiologically, and pathologically mimic serious conditions like neoplasia.
Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets
Aitchison, Ella E., Dimesa, Alexandra M. , Shoari, Alireza

BioTech | April 15, 2025 | Volume: 14 | Issue: 2 | Pages: 28

10.3390/biotech14020028 | PMID 40265458 Get It

Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteolytic enzymes that are crucial for the remodeling of the extracellular matrix, a process that is often co-opted by cancers, including brain tumors, to facilitate growth, invasion, and metastasis. In gliomas, MMPs contribute to a complex interplay involving tumor proliferation, angiogenesis, and immune modulation, thereby influencing tumor progression and patient prognosis. This review provides a comprehensive analysis of the roles of various MMPs in different types of gliomas, from highly malignant gliomas to metastatic lesions. Emphasis is placed on how the dysregulation of MMPs impacts tumor behavior, the association between specific MMPs and the tumor grade, and their potential as biomarkers for diagnosis and prognosis. Additionally, the current therapeutic approaches targeting MMP activity are discussed, exploring both their challenges and future potential. By synthesizing recent findings, this paper aims to clarify the broad significance of MMPs in gliomas and propose avenues for translational research that could enhance treatment strategies and clinical outcomes.